Study shows UK recall rise

Manufacturing missteps are behind the near quadrupling of drug and medical device recalls in the UK between 2004 and 2008. A study by marketing concern Blueview Group shows that recalls and product alerts climbed to 94 from just 22, with nearly two-thirds attributed to manufacturing defects.

The study finds that 12 percent of pharma recalls stem from labeling and packaging problems, according to an online report, while nine percent are due to compromised sterility.

Another finding: food product recalls have remained more stable during the rapid rise of pharma and non-food consumer product recalls and safety alerts.

- here's the report

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.